What is the interaction between tizanidine and valacyclovir?

Tizanidine and Valacyclovir Interaction

There is a clinically significant drug interaction between tizanidine and valacyclovir (acyclovir) that can cause significant hypotension, bradycardia, and excessive sedation, requiring close monitoring and dose reduction of tizanidine when used together.

Mechanism of Interaction

Valacyclovir (which converts to acyclovir in the body) is a CYP1A2 inhibitor that significantly reduces tizanidine clearance. According to FDA labeling, tizanidine is primarily metabolized by CYP1A2, and when combined with CYP1A2 inhibitors like acyclovir, significant hypotension, bradycardia, and sedation can occur 1. The guideline evidence explicitly lists acyclovir among the CYP1A2 inhibitors that interact with tizanidine 1.

Clinical Consequences

The interaction can manifest as:

• Hypotension (most common and clinically significant)
• Bradycardia
• Excessive sedation and somnolence
• Dizziness and ataxia
• Risk of falls and fractures (particularly in elderly patients)

Research data confirms that CYP1A2 inhibitors substantially increase tizanidine plasma concentrations, with disproportionality analysis showing elevated reporting odds ratios for hypotension when tizanidine is combined with CYP1A2 inhibitors 2.

Management Algorithm

If concurrent use is necessary:

1. Reduce tizanidine dose significantly during valacyclovir therapy - the FDA label recommends reducing individual doses rather than dosing frequency 3

2. Monitor closely for:

   • Blood pressure (orthostatic hypotension)
   • Heart rate (bradycardia)
   • Level of sedation
   • Dizziness and fall risk

3. Watch for indicators of tizanidine overdose: dry mouth, somnolence, asthenia, and dizziness 3

4. Consider alternative muscle relaxants if feasible, particularly in:

   • Elderly patients (who already have 4-fold decreased tizanidine clearance)
   • Patients with renal impairment (valacyclovir can cause neurotoxicity in this population 4)
   • Patients on multiple CNS depressants

Critical Caveats

• Renal function matters doubly: Both tizanidine clearance is reduced >50% in renal insufficiency 3, AND valacyclovir can cause neurotoxicity in renal impairment 4
• Elderly patients are at highest risk due to decreased tizanidine clearance and increased fall risk
• The interaction is often overlooked despite being well-documented 5
• Do not abruptly discontinue tizanidine if switching medications - taper slowly to avoid rebound hypertension, tachycardia, and hypertonia 1

Practical Recommendation

Avoid this combination when possible. If valacyclovir is needed for HSV treatment in a patient on tizanidine, consider temporarily holding or significantly reducing tizanidine during the antiviral course, or use an alternative antiviral if clinically appropriate. If continuation is necessary, reduce tizanidine to the lowest effective dose and implement intensive monitoring for cardiovascular and CNS adverse effects.